MedPath
FDA Approval

TERCONAZOLE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 19, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terconazole(4 mg in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

H.J. Harkins Company, Inc.

147681894

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

H.J. Harkins Company, Inc.

H.J. Harkins Company, Inc.

H.J. Harkins Company, Inc.

147681894

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TERCONAZOLE

Product Details

NDC Product Code
52959-811
Application Number
NDA019579
Marketing Category
NDA (C73594)
Route of Administration
VAGINAL
Effective Date
January 19, 2012
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
Code: 0KJ2VE664UClass: ACTIMQuantity: 4 mg in 1 g
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCNClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1YClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath